Abstract 1107 Poster Session IV, Tuesday, 5/4 (poster 228)
Indomethacin, a cyclooxygenase inhibitor, is currently being used to close patent ductus arteriosus' in premature neonates, but its effect on platelet aggregatory function has never been systematically studied. Inhaled nitric oxide (INO), a pulmonary vasodilator, has been recently introduced to treat infants with severe hypoxemic respiratory failure. As both agents are known to inhibit platelet aggregation, we here compared the magnitude and time-course of these effects in neonates.
Methods: From October 1997 to September 1998, we prospectively examined the collagen-induced platelet aggregatory function (Whole blood platelet-ionized calcium Lumi-aggrometer, Chrono-Log) in premature infants treated with indomethacin and compared that with critically ill infants treated with INO and mechanically ventilated neonates. Nineteen premature infants (birth weight 1020 ± 290 g, gestation 26 ± 3 weeks) treated with indomethacin were enrolled into the study. Eight critically ill infants (birth weight 2550 ± 1210 g, gestation 36 ± 6 weeks) treated with INO, and 10 mechanically ventilated neonates (birth weight 2430 ± 1220 g, gestation 35 ± 5 weeks) were recruited for comparison.
Results: Collagen (5 µg/mL) caused platelet aggregation of 24 ± 11 ohms in 19 premature infants before starting indomethacin (pretreatment baseline), which was not different from pretreatment baseline of 8 INO-treated infants (24 ± 9 ohms), and the aggregation response of 10 mechanically ventilated neonates (24 ± 8 ohms)(ANOVA). Indomethacin, given in 3 intravenous doses (0.2 mg/kg followed by 0.1 mg/kg at 12 and 36 hours later), significantly inhibited the ex-vivo platelet aggregatory response (26% of pretreatment baseline) (versus its pretreatment baseline and mechanically ventilated neonates, ANOVA). Indomethacin therapy caused persistent inhibition of platelet function for at least 24 hours after the third intravenous dose (54% of pretreatment baseline), and full normalization of platelet function occurred 3 to 7 days later. In contrast, critically ill infants treated with INO showed inhibited platelet function during INO (67% of pretreatment baseline) and normalized platelet function by 24 hours after discontinuation of INO.
Conclusion: We conclude that both agents cause reversible inhibition of platelet function, however, the effect of indomethacin is longer lasting than that of INO.
Author information
Authors and Affiliations
Additional information
(Spon by: David Schiff)
Rights and permissions
About this article
Cite this article
Cheung, PY., Peliowski, A. & Radomski, M. Differential Inhibition of Platelet Aggregation by Indomethacin and Inhaled Nitric Oxide in Critically Ill Infants. Pediatr Res 45, 189 (1999). https://doi.org/10.1203/00006450-199904020-01124
Issue Date:
DOI: https://doi.org/10.1203/00006450-199904020-01124
- Springer Nature America, Inc.